Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BIOLASE Inc (NASDAQ:BIOL)

0.68
Delayed Data
As of Oct 20
 +0.03 / +4.62%
Today’s Change
0.48
Today|||52-Week Range
1.90
-51.43%
Year-to-Date
No recent news for BIOLASE Inc.

Today’s Trading

Previous close0.65
Today’s open0.66
Day’s range0.65 - 0.69
Volume76,793
Average volume (3 months)138,533
Market cap$51.7M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+17.14%
Earnings growth (this year)+24.14%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+7.68%
P/E ratioNM
Price/Sales1.64
Price/Book2.08

Competitors

 Today’s
change
Today’s
% change
MLSSMilestone Scientific...+0.01+1.15%
PDEXPro-Dex Inc+0.05+0.65%
XRAYDentsply Sirona Inc+1.17+1.93%
ALGNAlign Technology Inc+4.03+2.05%
Data as of 4:14pm ET, 10/20/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$51.8M
Annual profit (last year)-$15.4M
Net profit margin-29.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Harold C. Flynn
Vice President-
Operations
Richard R. Whipp
Corporate headquarters
Irvine, California

Forecasts